- Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease - May 6, 2025
- Restaurants Canada is extremely pleased by City of St. John’s lowering patio fees by 85% - May 6, 2025
- Mar-Jac Poultry MS, LLC Surpasses One Million Man-Hours Without a Lost-Time Incident, Setting New Safety Benchmark - May 6, 2025
Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease
Antwerp, Belgium, May 6, 2025 – Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase...